[{"address1": "Building 4", "address2": "Suite 200 3000 El Camino Real", "city": "Palo Alto", "state": "CA", "zip": "94306", "country": "United States", "phone": "650 507 0669", "website": "https://180lifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Sir Marc  Feldmann Ph.D.", "age": 78, "title": "Co-Founder", "yearBorn": 1945, "fiscalYear": 2023, "totalPay": 232970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 75, "title": "Co-Founder & Director", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 168750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ozan  Pamir C.F.A.", "age": 31, "title": "CFO & Secretary", "yearBorn": 1992, "fiscalYear": 2023, "totalPay": 410241, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lloyd Blair Jordan L.L.B., M.B.A.", "title": "Interim CEO & Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Jagdeep  Nanchahal M.D., Ph.D.", "title": "Co-Founder & Chairman of Clinical Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  Assad", "title": "Director of IR", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.5, "open": 2.16, "dayLow": 1.8801, "dayHigh": 2.18, "regularMarketPreviousClose": 2.5, "regularMarketOpen": 2.16, "regularMarketDayLow": 1.8801, "regularMarketDayHigh": 2.18, "beta": 0.449, "forwardPE": -4.2391305, "volume": 193963, "regularMarketVolume": 193963, "averageVolume": 596117, "averageVolume10days": 79780, "averageDailyVolume10Day": 79780, "ask": 2.1, "askSize": 100, "marketCap": 1890724, "fiftyTwoWeekLow": 1.31, "fiftyTwoWeekHigh": 15.713, "fiftyDayAverage": 1.96562, "twoHundredDayAverage": 2.88443, "currency": "USD", "enterpriseValue": 1720002, "floatShares": 903049, "sharesOutstanding": 969602, "sharesShort": 32170, "sharesShortPriorMonth": 140830, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0332, "heldPercentInsiders": 0.02943, "heldPercentInstitutions": 0.06768, "shortRatio": 0.44, "shortPercentOfFloat": 0.0335, "impliedSharesOutstanding": 969602, "bookValue": -0.444, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -12550828, "trailingEps": -11.2, "forwardEps": -0.46, "lastSplitFactor": "1:19", "lastSplitDate": 1709078400, "enterpriseToEbitda": -0.195, "52WeekChange": -0.7839426, "SandP52WeekChange": 0.24014747, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ATNF", "underlyingSymbol": "ATNF", "shortName": "180 Life Sciences Corp.", "longName": "180 Life Sciences Corp.", "firstTradeDateEpochUtc": 1498570200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "556dc907-19b7-3c23-912e-861728bdcf7c", "messageBoardId": "finmb_587644367", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.95, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 1146288, "totalCashPerShare": 1.182, "ebitda": -8826971, "totalDebt": 442285, "quickRatio": 0.288, "currentRatio": 0.585, "returnOnAssets": -0.63501, "returnOnEquity": -3.98577, "freeCashflow": -4449469, "operatingCashflow": -4241737, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]